Akadeum Life Sciences, Inc. has announced early access to its microbubble-based T cell and B cell isolation kits. A radical simplification over existing technologies, the use of microbubbles enables users to perform the entire cell separation process within a single tube and without a magnet.

The company has recently completed a beta testing program where key opinion leaders from across the US performed testing and provided feedback.

“The results from our beta testing program were fantastic, and we already have testers becoming customers. As a result of the success of the program, we are scaling up to fully launch products in the early part of 2019,” said John Younger, MD, Akadeum’s Cofounder and Chief Technology Officer.

“Due to product demand and enthusiasm, we’ve decided to offer an Early Access Program before our full commercial launch,” Younger said.

Read full article here